Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 4x68.1

Crystal Structure of OP0595 complexed with AmpC

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.68 Å
Oligo State
homo-dimer
Ligands
2 x OP0: (2S,5R)-N-(2-aminoethoxy)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide(Covalent)
2 x NI: NICKEL (II) ION(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Morinaka, A. et al., OP0595, a new diazabicyclooctane: mode of action as a serine beta-lactamase inhibitor, antibiotic and beta-lactam 'enhancer. J.Antimicrob.Chemother. (2015)
Release Date
2015-07-01
Peptides
Beta-lactamase: AB
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B